Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio

/PRNewswire/ -- Astellas Venture Management LLC (President: William Watt, Ph.D., "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc....

Related Keywords

San Francisco ,California ,United States ,Tokyo ,Japan ,San Carlos ,Kenji Yasukawa ,Stevenr Deitcher ,Cellinfinity Bio ,Premal Patel ,Douglas Crawford ,William Watt ,Prnewswire Astellas Venture Management ,Astellas Pharma Inc ,Astellas Venture Management ,Mission Biocapital Biolabs ,Mission Biocapital ,Both Companieswin ,Astellas Pharma ,Future Innovator ,Astellas Future Innovation Prize ,Labs General ,Future Innovator Prize ,Astellas Biomedical Innovation Hub ,Astellas Future Innovator Prize ,Focus Area Approach ,Genetic Regulation ,Cell Therapy ,Weatherwax Biotechnologies ,Astella Focus Area ,